| The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1. Mocquet V., Neusiedler J., Rende F., Cluet D., Robin J.P., Terme J.M., Duc Dodon M., Wittmann J., Morris C., Le Hir H. et al.
J. Virol. 86:7530-7543(2012) · Mapped (8) |
| INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation. Neusiedler J., Mocquet V., Limousin T., Ohlmann T., Morris C., Jalinot P.
RNA 18:1163-1177(2012) · Mapped (6) |
| INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells. Morris C., Tomimatsu N., Richard D.J., Cluet D., Burma S., Khanna K.K., Jalinot P.
Cancer Res. 72:2006-2016(2012) · Mapped (4) |
| Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1. Terme J.M., Mocquet V., Kuhlmann A.S., Zane L., Mortreux F., Wattel E., Duc Dodon M., Jalinot P.
Leukemia 23:2081-2089(2009) · Mapped (4) |
| TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation. Terme J.M., Lhermitte L., Asnafi V., Jalinot P.
Blood 113:6695-6698(2009) · Mapped (18) |
| Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1. Terme J.M., Wencker M., Favre-Bonvin A., Bex F., Gazzolo L., Duc Dodon M., Jalinot P.
J. Virol. 82:7913-7922(2008) · Mapped (4) |
| Human INT6/eIF3e is required for nonsense-mediated mRNA decay. Morris C., Wittmann J., Jaeck H.-M., Jalinot P.
EMBO Rep. 8:596-602(2007) · UniProtKB (4) · Mapped (3) |
| Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle. Buchsbaum S., Morris C., Bochard V., Jalinot P.
Oncogene 26:5132-5144(2007) · UniProtKB (1) · Mapped (10) |
| Modulation of HIV-1 Rev protein abundance and activity by polyubiquitination with unconventional Lys-33 branching. Vitte A.L., Buchsbaum S., Jalinot P.
FEBS Lett. 580:6155-6160(2006) · Mapped (3) |
| Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome. Favre-Bonvin A., Reynaud C., Kretz-Remy C., Jalinot P.
J. Virol. 79:4229-4237(2005) · Mapped (13) |
| Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B-Cdk1 activation. Morris C., Jalinot P.
Oncogene 24:1203-1211(2005) · Mapped (4) |
| Association of the mammalian proto-oncoprotein Int-6 with the three protein complexes eIF3, COP9 signalosome and 26S proteasome. Hoareau Alves K., Bochard V., Rety S., Jalinot P.
FEBS Lett. 527:15-21(2002) · UniProtKB (5) · Mapped (3) |
| The human protein HSPC021 interacts with Int-6 and is associated with eukaryotic translation initiation factor 3. Morris-Desbois C., Rety S., Ferro M., Garin J., Jalinot P.
J. Biol. Chem. 276:45988-45995(2001) · UniProtKB (2) |
| The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element. Reynaud C., Fabre S., Jalinot P.
J. Biol. Chem. 275:33962-33968(2000) · UniProtKB (3) · Mapped (4) |
| Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies. Morris-Desbois C., Bochard V., Reynaud C., Jalinot P.
J. Cell Sci. 112:3331-3342(1999) · UniProtKB (3) |
| The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Rousset R., Fabre S., Desbois C., Bantignies F., Jalinot P.
Oncogene 16:643-654(1998) · UniProtKB (7) |
| Human TAF(II)28 interacts with the human T cell leukemia virus type I Tax transactivator and promotes its transcriptional activity. Caron C., Mengus G., Dubrowskaya V., Roisin A., Davidson I., Jalinot P.
Proc. Natl. Acad. Sci. U.S.A. 94:3662-3667(1997) |
| Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Rousset R., Desbois C., Bantignies F., Jalinot P.
Nature 381:328-331(1996) · UniProtKB (2) |
| Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Desbois C., Rousset R., Bantignies F., Jalinot P.
Science 273:951-953(1996) · UniProtKB (1) |
| Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. Veschambre P., Simard P., Jalinot P.
J. Mol. Biol. 250:169-180(1995) · UniProtKB (2) |
